MAY 22·Zacks CommentaryMed
Jones Soda Q1 Loss Narrows Y/Y, Expenses Reduce, Revenues Fall 7.8%
JSDA trims Q1 losses with cost cuts and HD9 growth, but revenue slips 7.8% amid tough comps and rising promotional expenses.
JONES SODA CO.
No enriched coverage for $JSDA in the last 7 days.
No SEC Form 4 filings for $JSDA in the last 30 days.
JSDA trims Q1 losses with cost cuts and HD9 growth, but revenue slips 7.8% amid tough comps and rising promotional expenses.